Abolghasemi M, Poursaei E, Bornehdeli S, Shanehbandi D, Asadi M, Sadeghzadeh M, Sadeh RN (2021) Exploration of potential circulating micro-RNA as biomarker for Alzheimer’s disease. Meta Gene 30:100968
Abolghasemi M, Ali Ashrafi S, Asadi M, Shanehbandi D, Sadigh Etehad S, Poursaei E, Shaafi S (2023) MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose. Mol Biol Rep 50(1):167–172
Article CAS PubMed Google Scholar
Adlakha YK, Saini N (2014) Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer 13(1):1–18
Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D, Concepcion CP (2011) microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci 108(52):21099–21104
Article CAS PubMed PubMed Central Google Scholar
Amoruso A, Blonda M, Gironi M, Grasso R, Di Francescantonio V, Scaroni F, Avolio C (2020) Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients. Sci Rep 10(1):6125
Article CAS PubMed PubMed Central Google Scholar
Aquino J, Bolontrade M, Garcia M, Podhajcer O, Mazzolini G (2010) Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Ther 17(6):692–708
Article CAS PubMed Google Scholar
Aranda P, Agirre X, Ballestar E, Andreu EJ, Roman-Gomez J, Prieto I, Esteller M (2009) Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS ONE 4(11):e7809
Article PubMed PubMed Central Google Scholar
Arora S, Rana R, Chhabra A, Jaiswal A, Rani V (2013) miRNA–transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics 288:77–87
Article CAS PubMed Google Scholar
Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97(4):742–768
Article CAS PubMed Google Scholar
Barati S, Tahmasebi F, Faghihi F (2020) Effects of mesenchymal stem cells transplantation on multiple sclerosis patients. Neuropeptides 84:102095
Article CAS PubMed Google Scholar
Barwari T, Joshi A, Mayr M (2016) MicroRNAs in cardiovascular disease. J Am Coll Cardiol 68(23):2577–2584
Article CAS PubMed Google Scholar
Baulina N, Kulakova O, Kiselev I, Osmak G, Popova E, Boyko A, Favorova O (2018) Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission. J Neuroimmunol 317:67–76
Article CAS PubMed Google Scholar
Blonda M, Amoruso A, Grasso R, Di Francescantonio V, Avolio C (2017) Multiple sclerosis treatments affect monocyte-derived microvesicle production. Front Neurol 8:422
Article PubMed PubMed Central Google Scholar
Boissart C, Nissan X, Giraud-Triboult K, Peschanski M, Benchoua A (2012) miR-125 potentiates early neural specification of human embryonic stem cells. Development 139(7):1247–1257
Article CAS PubMed Google Scholar
Brownlee WJ, Hardy TA, Fazekas F, Miller DH (2017) Diagnosis of multiple sclerosis: progress and challenges. Lancet 389(10076):1336–1346
Buhagiar A, Borg J, Ayers D (2020) Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions. Non-Coding RNA Res 5(1):22–26
Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78(9):838–848
Article CAS PubMed Google Scholar
Caplan A (2009) Why are MSCs therapeutic? New data: new insight. J Pathol: J Pathol Soc Great Britain Ireland 217(2):318–324
Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136(4):642–655
Article CAS PubMed PubMed Central Google Scholar
Ceolotto G, Giannella A, Albiero M, Kuppusamy M, Radu C, Simioni P, Iori E (2017) miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways. Cardiovasc Res 113(13):1627–1638
Article CAS PubMed Google Scholar
Chavakis E, Dimmeler S (2011) Homing of progenitor cells to ischemic tissues. Antioxid Redox Signal 15(4):967–980
Article CAS PubMed Google Scholar
Chen C-Z, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303(5654):83–86
Article CAS PubMed Google Scholar
Chen TS, Lai RC, Lee MM, Choo ABH, Lee CN, Lim SK (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38(1):215–224
Article CAS PubMed Google Scholar
Cheng L-C, Pastrana E, Tavazoie M, Doetsch F (2009) miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 12(4):399–408
Article CAS PubMed PubMed Central Google Scholar
Choi YJ, Lin C-P, Ho JJ, He X, Okada N, Bu P, Chen C (2011) miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13(11):1353–1360
Article CAS PubMed PubMed Central Google Scholar
Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Camussi G (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 5(7):e11803
Article PubMed PubMed Central Google Scholar
Crop M, Baan C, Weimar W, Hoogduijn M (2009) Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int 22(4):365–376
Article CAS PubMed Google Scholar
Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, Jiang Y (2020) Exosomes: key players in cancer and potential therapeutic strategy. Signal Trans Target Ther 5(1):145
De Santis G, Ferracin M, Biondani A, Caniatti L, Tola MR, Castellazzi M, Fainardi E (2010) Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 226(1–2):165–171
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement. Cytotherapy 8:315–317
Article CAS PubMed Google Scholar
Duan Y, Luo Q, Wang Y, Ma Y, Chen F, Zhu X, Shi J (2020) Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy. J Biol Chem 295(37):12868–12884
Article CAS PubMed PubMed Central Google Scholar
Ehya F, Tehrani HA, Garshasbi M, Nabavi SM (2017) Identification of miR-24 and miR-137 as novel candidate multiple sclerosis miRNA biomarkers using multi-staged data analysis protocol. Mol Biol Res Commun 6(3):127
CAS PubMed PubMed Central Google Scholar
Essandoh K, Li Y, Huo J, Fan G-C (2016) MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock (augusta, Ga) 46(2):122
Article CAS PubMed Google Scholar
Faissner S, Plemel JR, Gold R, Yong VW (2019) Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat Rev Drug Discov 18(12):905–922
Article CAS PubMed Google Scholar
Fayyad-Kazan H, Hamade E, Rouas R, Najar M, Fayyad-Kazan M, El Zein N, Al-Akoum C (2014) Downregulation of microRNA-24 and-181 parallels the upregulation of IFN-γ secreted by activated human CD4 lymphocytes. Hum Immunol 75(7):677–685
Article CAS PubMed Google Scholar
Fenoglio C, Ridolfi E, Cantoni C, De Riz M, Bonsi R, Serpente M, Alvarez E (2013) Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult Scler J 19(14):1938–1942
Gallo S, Gili M, Lombardo G, Rossetti A, Rosso A, Dentelli P, Camussi G (2016) Stem cell-derived, microRNA-carrying extracellular vesicles: a novel approach to interfering with mesangial cell collagen production in a hyperglycaemic setting. PLoS ONE 11(9):e0162417
留言 (0)